GATA2-related myeloid neoplasms in pediatrics: where do we stand?

Pediatr Hematol Oncol. 2022 May;39(4):365-369. doi: 10.1080/08880018.2021.1987600. Epub 2021 Oct 20.

Authors

Manuela Spadea¹, Paola Quarello¹, Francesco Saglio¹, Lucia Pedace², Franca Fagioli¹

Affiliations

¹ Pediatric Oncohematology, Stem Cell Transplantation and Cell Therapy Division, A.O.U. Città della Salute e della Scienza-Regina Margherita Children's Hospital, Turin, Italy.
² Department of Pediatric Hematology/Oncology and Cellular and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

PMID: 34668827
DOI: 10.1080/08880018.2021.1987600

No abstract available

Keywords: GATA-2; acute myeloid leukemia; myelodysplastic syndromes; next-generation sequencing.

Publication types

Letter

MeSH terms

Child
GATA2 Transcription Factor
Humans
Leukemia, Myeloid, Acute* / genetics
Leukemia, Myeloid, Acute* / therapy
Mutation
Neoplasms*
Pediatrics*

Substances

GATA2 Transcription Factor
GATA2 protein, human